ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ

Эффективность внутрикостного введения аутологичной обогащенной тромбоцитами плазмы в зону отека костного мозга при остеоартрозе коленного сустава

А. В. Лычагин, А. В. Гаркави, О. И. Ислейих, П. И. Катунян, Д. С. Бобров, Р. Х. Явлиева, Е. Ю. Целищева
Информация об авторах

Первый Московский государственный медицинский университет имени И. М. Сеченова, Москва, Россия

Для корреспонденции: Осама Ибрахим Ислейих
ул. Большой Тишинский переулок, д. 26/15, г. Москва, 123557; moc.oohay@osbiaso

Информация о статье

Вклад авторов в работу: А. В. Лычагин и О. И. Ислейих — планирование исследования, подбор литературы, интерпретация данных, подготовка черновика рукописи; А. В. Гаркави — планирование исследования, интерпретация данных; П. И. Катунян — планирование исследования, подготовка черновика рукописи; Д. С. Бобров, Р. Х. Явлиева и Е. Ю. Целищева — планирование исследования.

Статья получена: 12.07.2019 Статья принята к печати: 26.07.2018 Опубликовано online: 20.08.2019
|
  1. Felson DT, McLaughlin S, Goggins J, LaValley MP, Gale ME, Totterman S, et al. Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern Med. 2003; (139): 330–6.
  2. Kazakia GJ, Kuo D, Schooler J, Siddiqui S, Shanbhag S, Bernstein G et al. Arthritis Research & Therapy. 2013; (15): 11–2.
  3. Meizer R, Radda C, Stolz G, Kotsaris S, Petje G, Krasny C, et al. MRI-controlled analysis of 104 patients with painful bone marrow edema in different joint localizations treated with the prostacyclin analogue iloprost. Wien Klin Wochenschr. 2005; (117): 278–86.
  4. Зайцева Е. М. Оценка минеральной плотности костной ткани субхондральных отделов бедренной и большеберцовой костей при гонартрозе. Научно-практическая ревматология. 2005; (1): 27–30.
  5. Felson DT. An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin North Am. 2004; (42): 1–9.
  6. Алексеева Л. И., Зайцева Е. М. Роль субхондральной кости при остеоартрозе. НИИ ревматологии РАМН. Научно- практическая ревматология. М., 2009; (4): 43–8.
  7. Delgado D, Garate A, Vincent H, Bilbao AM, Patel R, Fiz N, at al. Current concepts in intraosseous Platelet-Rich Plasma injections for knee osteoarthritis. Journal of Clinical Orthopaedics and Trauma. 2019; (10): 36–4.
  8. Roemer FW, Frobell R, Hunter DJ, Crema MD, Fischer W, Bohndorf K, et al. MRI-detected subchondral bone marrow signal alterations of the knee joint: terminology, imaging appearance, relevance and radiological differential diagnosis. Osteoarthritis Cartilage. 2009; (17): 1115–31.
  9. Roemer FW, Neogix T, Nevittk MC, Felsonx DT, Zhux Y, Zhangx Y, et al. Subchondral bone marrow lesions are highly associated with and predict subchondral bone attrition longitudinally. The MOST study Osteoarthritis and Cartilage. 2010; (18): 47–53.
  10. Sowers MF, Hayes C, Jamadar D, Capul D, Lachance L, Jannausch M, et al. Magnetic resonance-detected subchondral bone marrow and cartilage defect characteristics associated with pain and X-ray-defined knee osteoarthritis. Osteoarthritis and Cartilage. 2003; (6): 387–393.
  11. Wilson AJ, Murphy WA, Hardy DC, Totty WG. Transient osteoporosis: transient bone marrow edema? Radiology. 1988; (167): 757–760.
  12. Lecouvet FE, van de Berg BC, Maldague BE, Lebon CJ, Jamart J, Saleh M, et al. Early irreversible osteonecrosis versus transient lesions of the femoral condyles: prognostic value of subchondral bone and marrow changes on MR imaging. AJR Am J Roentgenol. 1998; (170): 71–7.
  13. Hunter DJ, Gerstenfeld L, Bishop G, Davis AD, Mason ZD, Einhorn TA, et al. Bone marrow lesions from osteoarthritis knees are characterized by sclerotic bone that is less well mineralized. Arthritis Res Ther. 2009; (11): 11.
  14. Manicourt DH, Brasseur JP, Boutsen Y, Depreseux G, Devogelaer JP. Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity. Arthritis Rheum. 2004; (50): 3690–97.
  15. Pelletier JP, Raynauld JP, Berthiaume MJ, Abram F, Choquette D, Haraoui B, et al. Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study. Arthritis Research and Therapy. 2007; (4): 74.
  16. Zhao J, Li X, Bolbos RI, Link TM, Majumdar S. Longitudinal assessment of bone marrow edema-like lesions and cartilage degeneration in osteoarthritis using 3 T MR T1rho quantification. Skeletal Radiol. 2010: (39): 523–31.
  17. Carrino JA, Blum J, Parellada JA, Schweitzer ME, Morrison WB. MRI of bone marrow edema-like signal in the pathogenesis of subchondral cysts. Osteoarthritis Cartilage. 2006; (14): 1081–15.
  18. Peterfy CG, Guermazi A, Zaim S, Tirman PF, Miaux Y, White D, et al. Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. Osteoarthritis and Cartilage. 2004; 12 (3): 177–90.
  19. Wluka AE, Hanna F, Davies-Tuck M, Wang Y, Bell RJ, Davis SR, et al. Bone marrow lesions predict increase in knee cartilage defects and loss of cartilage volume in middle-aged women without knee pain over 2 years. Ann Rheum Dis. 2009; (68): 850–5.
  20. Iida S, et al. Correlation between bone marrow edema and collapse of the femoral head in steroid-induced osteonecrosis. AJR. American Journal of Roentgenology. 2000; 174 (3): 735–43.
  21. Ito H, Matsuno T, Minami A. Relationship between bone marrow edema and development of symptoms in patients with osteonecrosis of the femoral head. AJR. American Journal of Roentgenology. 2006; 186 (6): 1761–70.
  22. Perry T, O'Neill T, Parkes M, Felson DT, Hodgson R, Arden NK. Bone marrow lesion type and pain in knee osteoarthritis. Ann Rheum Dis. 2018; (77): 1145.
  23. Tanamas SK, Wluka AE, Pelletier JP, Pelletier JM, Abram F, Berry PA, et al. Bone marrow lesions in people with knee osteoarthritis predict progression of disease and joint replacement. A longitudinal study Rheumatology. 2010; (49): 2413–19.
  24. Berger CE, Kroner AH, Minai-Pour MB, Ogris E, Engel A. Biochemical markers of bone metabolism in bone marrow edema syndrome of the hip. Bone. 2003; (33): 346–51.
  25. Kuttapitiya A, Assi L, Laing K, Hing C, Mitchell P, Whitley G, et al. Microarray analysis of bone marrow lesions in osteoarthritis demonstrates upregulation of genes implicated in osteochondral turnover, neurogenesis and inflammation. Ann Rheum Dis. 2017; 76 (10): 1764–73.
  26. Astur DC, de Freitas EV, Cabral PB, Morais CC, Pavei BS, Kaleka CC, et al. Evaluation and management of subchondral calcium phosphate injection technique to treat bone marrow lesion Cartilage. 2018; (10): 1177.
  27. Su K, Bai Y, Wang J, Zhang H, Liu H, Ma S. Comparison of hyaluronic acid and PRP intra-articular injection with combined intra-articular and intraosseous PRP injections to treat patients with knee osteoarthritis. 2018; (37): 1341–50.
  28. Fiz N, Pérez JC, Guadilla J, Garate A, Sánchez P, Padilla S, et al. Intraosseous Infiltration of Platelet-Rich Plasma for Severe Hip Osteoarthritis. 2017; 19 (6): 821–5.
  29. Sánchez M, Anitua E, Delgado D, Sanchez P, Prado R, Goiriena JJ, et al. A new strategy to tackle severe knee osteoarthritis: Combination of intra-articular and intraosseous injections of Platelet Rich Plasma. Expert Opinion on Biological Therapy. 2016; (10): 15–7.
  30. Kellgren JH, JeVrey M, Ball J. Atlas of standard radiographs. Vol 2. Oxford: Blackwell Scientific, 1963.
  31. Roos E, Lohmander L. The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health and Quality of Life Outcomes. 2003; 1 (1): 64–72.
  32. Marot V, Murgier J, Carrozzo A, Reina N, Monaco E, Chiron P et al. Determination of normal KOOS and WOMAC values in a healthy population. Knee Surgery, Sports Traumatology, Arthroscopy. 2018; 27 (2): 541–8.
  33. Hawker G, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF. Arthritis Care & Research. 2011; 63 (S11): S240-52.